Could Achieve Life Sciences, Inc. (ACHV) Recover After Today’s Significant Decline?

June 14, 2018 - By reb123z

The stock of Achieve Life Sciences, Inc. (NASDAQ:ACHV) is a huge mover today! The stock decreased 25.18% or $1.75 during the last trading session, reaching $5.2. About 230,405 shares traded or 357.95% up from the average. Achieve Life Sciences, Inc. (NASDAQ:ACHV) has declined 74.49% since June 15, 2017 and is downtrending. It has underperformed by 87.06% the S&P500.
The move comes after 9 months negative chart setup for the $6.71M company. It was reported on Jun, 15 by Barchart.com. We have $4.73 PT which if reached, will make NASDAQ:ACHV worth $604,080 less.

More important recent Achieve Life Sciences, Inc. (NASDAQ:ACHV) news were published by: Benzinga.com which released: “31 Stocks Moving In Thursday’s Mid-Day Session” on June 14, 2018, also Benzinga.com published article titled: “28 Stocks Moving In Wednesday’s Mid-Day Session”, Benzinga.com published: “42 Stocks Moving In Thursday’s Mid-Day Session” on May 24, 2018. More interesting news about Achieve Life Sciences, Inc. (NASDAQ:ACHV) was released by: Prnewswire.com and their article: “Achieve Life Sciences, Inc. Announces Reverse Stock Split” with publication date: May 23, 2018.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company has market cap of $6.71 million. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: